Pharmacological augmentation of motor recovery after stroke: antidepressants for non-depressed patients?
Stroke remains the most common cause of adult physical disability worldwide, and standard physical rehabilitation methods have limited effectiveness. Thus, the possibility of augmenting motor recovery after stroke using drugs has obvious attractions.
Tallelli
P
P
Sobell Department of Motor Neuroscience and Movement Disorders, Institute of Neurology, Queen Square, London WC1N 3BG, UK.
Werring
D J
DJ
D018687:Antidepressive Agents, Second-Generation / Q000494:pharmacology* / Q000627:therapeutic use; D015283:Citalopram / Q000494:pharmacology* / Q000627:therapeutic use; D002986:Clinical Trials as Topic / Q000379:methods / Q000592:standards; D003866:Depressive Disorder / Q000188:drug therapy / Q000209:etiology; D007839:Functional Laterality / Q000187:drug effects / Q000502:physiology; D006801:Humans; D009044:Motor Cortex / Q000187:drug effects* / Q000503:physiopathology; D017063:Outcome Assessment, Health Care / Q000379:methods; D020127:Recovery of Function / Q000187:drug effects* / Q000502:physiology; D015203:Reproducibility of Results; D012720:Severity of Illness Index; D020521:Stroke / Q000150:complications / Q000188:drug therapy* / Q000503:physiopathology
D018687:Antidepressive Agents, Second-Generation; D015283:Citalopram